Results 211 to 220 of about 187,564 (302)

Shaping the future of abdominal and pelvic pain research with novel scientific and technological advances. [PDF]

Front Pain Res (Lausanne)
Malykhina AP.
europepmc   +1 more source

Botulinum toxin use in patients with neurological disorders: A U.S.‐based claims database analysis

PM&R, EarlyView.
Abstract Background and Objective Real‐world evidence describing long‐term persistency with botulinum toxin (BoNT) therapy is limited. We assessed treatment patterns and persistency with BoNT in clinical practice over 2 years. Design Retrospective, longitudinal, claims database analysis. Setting Medical claims data from the Merative MarketScan database
David M. Simpson, Jonathan Bouchard, Simon Page, Seth Goldfarb, Atul T. Patel   +4 more
wiley   +1 more source

Effects of Robot-Assisted Gait Therapy on Urodynamic Changes in the Subacute Phase After Spinal Cord Injury: A Prospective Study. [PDF]

Med Sci Monit
Ziętek Z, Frasuńska J, Korczyński B, Szopiński T, Tarnacka B.   +4 more
europepmc   +1 more source

MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Precision Radiation Oncology, EarlyView.
MRI, owing to its superior soft tissue contrast and spatial resolution, has become the preferred noninvasive modality for assessing nCRT efficacy. This review synthesizes current evidence on MRI‐based assessment of nCRT efficacy in LARC and discusses future directions.
Shuang Chen, Lin Liu, Guangwei Tian, Ruimei Chai   +3 more
wiley   +1 more source

Recurrent urinary tract infections and psychological burden: mechanisms and integrative perspectives. [PDF]

Front Med (Lausanne)
Qian T, He Y, Yan R, Yu S, Chen Y, He W.
europepmc   +1 more source

A Pilot Study of 18F‐rhPSMA‐7.3‐PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease

The Prostate, EarlyView.
ABSTRACT Introduction PSMA‐PET offers an opportunity to reduce the mischaracterization of disease in active surveillance (AS) and focal therapy (FT) candidates. We describe the results of a pilot clinical trial evaluating 18F‐radiohybrid(rh)PSMA‐7.3‐PET/MRI to detect occult adverse pathology among potential AS and FT candidates (NCT05852041).
Ridwan Alam, Derek Hesse, Nikki Hubbard, Emma McGarrity, Sai Kumar, Clayton Neill, Yutai Li, Nicole Handa, Hiten D. Patel, Edward M. Schaeffer, Hatice Savas, Ashley E. Ross   +11 more
wiley   +1 more source

Re: Tyagi comments on "<i>In situ</i> observation of urothelial responses to NaCl-induced osmotic stress using optical coherence tomography". [PDF]

J Biomed Opt
Wang H, Zhu H.
europepmc   +1 more source

Exploring the Gut‐Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder Function

The Prostate, EarlyView.
ABSTRACT Background Benign prostatic hyperplasia (BPH) is a common urologic condition in aging men, often linked to systemic inflammation and metabolic dysfunction. Emerging evidence suggests that the gut microbiome may contribute to prostate health and disease.
Jonathan Surber, Marie Lork, Yasser Morsy, Michael Scharl, Daniel Stephan Engeler, Janine Langenauer, Lukas John Hefermehl, Anna Ebner, Basil Kaufmann, Manuela Hunziker, Daniel Eberli, Uwe Bieri, Cédric Poyet   +12 more
wiley   +1 more source

Construction and Validation of a Nomogram for Diagnosis of Female Stress Urinary Incontinence Combined with Anatomic/Intrinsic Urethral Sphincter Deficiency. [PDF]

Int J Womens Health
Hu G, Zhou L, Su W, Tang G, Zhao D, Tang J.   +5 more
europepmc   +1 more source